Towards Treatment of Pediatric Tuberculosis with IFN-?
Jean-Laurent Casanova of The Rockefeller University in the U.S. seeks to identify single gene mutations that are critical to immunity against bacterial infections. By characterizing these mutations, Casanova could provide insight into a genetic basis for the susceptibility of some children to Tuberculosis, that could inform a recombinant IFN-y drug therapy.